Cargando…
Steering CAR T cell epigenetic programs by tweaking manufacturing protocol
CAR T cell persistence remains a significant roadblock to effective clinical translation of CAR T cells for solid and brain tumors. Jung et al.(1) demonstrate enrichment of resident memory phenotypes through simple changes to the CAR T cell manufacturing process.
Autores principales: | Dukes, Meghan W., Krenciute, Giedre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313927/ https://www.ncbi.nlm.nih.gov/pubmed/37343521 http://dx.doi.org/10.1016/j.xcrm.2023.101080 |
Ejemplares similares
-
Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?
por: Prinzing, Brooke, et al.
Publicado: (2021) -
MDB-20. IMPROVING THE PERSISTENCE OF CAR T CELLS AGAINST GROUP 3 MEDULLOBLASTOMAS VIA EPIGENETIC REGULATION OF EXHAUSTION
por: Dukes, Meghan, et al.
Publicado: (2023) -
CAR NK Cell Therapy for T Follicular Helper Cells
por: King, Cecile
Publicado: (2020) -
Open for connections: HiCAR reveals the interactions of accessible DNA
por: Moindrot, Benoit, et al.
Publicado: (2022) -
Through Ancient Rings Thread Programming Strings
por: Symmons, Martyn F., et al.
Publicado: (2009)